2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
Summary The International Initiative on Thrombosis and Cancer is an independent
academic working group of experts aimed at establishing global consensus for the treatment …
academic working group of experts aimed at establishing global consensus for the treatment …
[HTML][HTML] COVID‐19 anticoagulation recommendations in children
M Loi, B Branchford, J Kim, C Self… - Pediatric blood & …, 2020 - ncbi.nlm.nih.gov
To the Editor: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, is often associated with hypercoagulability …
syndrome coronavirus 2 (SARS-CoV-2) infection, is often associated with hypercoagulability …
Direct oral anticoagulants for use in paediatrics
J Jaffray, G Young - The Lancet Child & Adolescent Health, 2022 - thelancet.com
With the increasing incidence of thromboembolism in children and improvement in
management for patients with medically complex diseases, expanded availability of safe …
management for patients with medically complex diseases, expanded availability of safe …
[HTML][HTML] Clinical characteristics and risk factors associated with ICU-acquired infections in sepsis: a retrospective cohort study
Y He, J Xu, X Shang, X Fang, C Gao, D Sun… - Frontiers in cellular …, 2022 - frontiersin.org
Intensive care unit (ICU)-acquired infection is a common cause of poor prognosis of sepsis
in the ICU. However, sepsis-associated ICU-acquired infections have not been fully …
in the ICU. However, sepsis-associated ICU-acquired infections have not been fully …
COVID-19-induced coagulopathy: Experience, achievements, prospects
The presence of coagulopathy as part of the systemic inflammatory response syndrome is a
characteristic feature of severe coronavirus disease 2019 (COVID-19). Hematological …
characteristic feature of severe coronavirus disease 2019 (COVID-19). Hematological …
Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)
K Thom, AWA Lensing, I Nurmeev, F Bajolle… - Blood …, 2020 - ashpublications.org
Anticoagulant treatment of pediatric central venous catheter–related venous
thromboembolism (CVC-VTE) has not been specifically evaluated. In EINSTEIN-Jr, 500 …
thromboembolism (CVC-VTE) has not been specifically evaluated. In EINSTEIN-Jr, 500 …
Development of a risk model for pediatric hospital-acquired thrombosis: a report from the Children's Hospital-Acquired Thrombosis Consortium
J Jaffray, B Branchford, N Goldenberg, J Malvar… - The Journal of …, 2021 - Elsevier
Objective To identify pertinent clinical variables discernible on the day of hospital admission
that can be used to assess risk for hospital-acquired venous thromboembolism (HA-VTE) in …
that can be used to assess risk for hospital-acquired venous thromboembolism (HA-VTE) in …
Do antimicrobial and antithrombogenic peripherally inserted central catheter (PICC) materials prevent catheter complications? An analysis of 42,562 hospitalized …
Objective: To examine the effectiveness of antimicrobial and antithrombogenic materials
incorporated into peripherally inserted central catheters (PICCs) to prevent bloodstream …
incorporated into peripherally inserted central catheters (PICCs) to prevent bloodstream …
[HTML][HTML] Central venous catheter–associated complications in pediatric patients diagnosed with Hodgkin lymphoma: implications for catheter choice
CH van den Bosch, J Spijkerman, MHWA Wijnen… - Supportive Care in …, 2022 - Springer
Purpose The purpose of this study was to determine the most optimal central venous
catheter (CVC) for pediatric patients with Hodgkin lymphoma (HL) in terms of complications …
catheter (CVC) for pediatric patients with Hodgkin lymphoma (HL) in terms of complications …
In defense of the use of peripherally inserted central catheters in pediatric patients
Central venous access devices have revolutioned the care of children affected by
malignancies, facilitating management of complex and prolonged infusive therapies …
malignancies, facilitating management of complex and prolonged infusive therapies …